In the early stages of cancer, M1 TAMs are present, participating in the inflammatory response and expressing many pro-inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin-2 (IL-2), IL-6, IL-12, IL-23, nitric oxide (NO) and reactive oxygen species (ROS). This evidence concerns the gene IL2 and cancer.